Additional file 8: Table S8A-F. of Metronomic cyclophosphamide activation of anti-tumor immunity: tumor model, mouse host, and drug schedule dependence of gene responses and their upstream regulators

KEGG pathways and DAVID clusters enriched in genes that are specifically expressed at a higher or a lower level in untreated GL261(B6) tumors when compared to LLC and B16F10 tumors and in the sets of genes that respond to CPA/6d treatment. (XLSX 186 kb)